Showing results (1061-1070 of 1,219) with videos related to

Sort By:
Pageof 122
Environmental Microbiology|December 5, 2014
Genomic and proteomic characterization of two novel siphovirus infecting the sedentary facultative epibiont cyanobacterium Acaryochloris marinaYi-Wah Chan, Andrew D Millard, Peter J Wheatley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium studyKurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
Oncotarget|July 13, 2015
Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trialsIshwaria M Subbiah, Gerald S Falchook, Ahmed O Kaseb, et al.
Trials|December 17, 2021
Update to the study protocol for an implementation-effectiveness trial comparing two education strategies for improving the uptake of noninvasive ventilation in patients with severe COPD exacerbationMihaela S Stefan, Penelope S Pekow, Christopher M Shea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cellsGuido M Sclabas, Shuichi Fujioka, Christian Schmidt, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapyMehmet Asim Bilen, Kenneth R Hess, Sumit K Subudhi, et al.
American Journal of Clinical Pathology|September 14, 2017
Building a New Transfusion ServiceJohn R Hess, Brenda K Hayden, Virginia G Cruz-Cody, et al.
Plos One|October 12, 2017
Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificitiesEllen M Leitman, Christine D Palmer, Søren Buus, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumorsCoya Tapia, Phyu P Aung, Sinchita Roy-Chowdhuri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomasVictor A Levin, Kenneth R Hess, Ali Choucair, et al.
Pageof 122